Global Biomarker of Disease Market Growth (Status and Outlook) 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
Omics, proteomics, meta-bolomics technologies are used in biomarkers discovery and disease diagnosis. Biomarkers are used in risk assessment, molecular diagnostic, disease diagnosis, DNA fingerprinting and other molecular applications. Biomarkers enable pharmaceutical companies to analyze and discover novel drugs as demand for cost effective and efficient treatment dose is increasing. Biomarkers are used in drug validation and testing, sample preparation and assay development to eliminate complexity in discovery and development of novel drugs. Biomarkers of disease are used in identification of disease condition and also help in validation of clinical trials for novel drug.
The global Biomarker of Disease market size is projected to grow from US$ 31640 million in 2024 to US$ 79080 million in 2030; it is expected to grow at a CAGR of 16.5% from 2024 to 2030.
LPI (LP Information)' newest research report, the “Biomarker of Disease Industry Forecast” looks at past sales and reviews total world Biomarker of Disease sales in 2022, providing a comprehensive analysis by region and market sector of projected Biomarker of Disease sales for 2023 through 2029. With Biomarker of Disease sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Biomarker of Disease industry.
This Insight Report provides a comprehensive analysis of the global Biomarker of Disease landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Biomarker of Disease portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Biomarker of Disease market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Biomarker of Disease and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Biomarker of Disease.
According to the Global Use of Medicines 2023 released by IQVIA Institute, the global drug expenditure in 2022 was about US$1.48 trillion (excluding COVID vaccine and treatment-related expenses), and it is predicted to grow at a rate of 3%-6% in the next few years. In terms of drug expenditure, this number in China was about 166 billion dollars in 2022. It is expected that the expenditure on medicines will increase in the next few years. From the perspective of demand, the trend of population aging, the increase of residents’ wealth and the improvement of health awareness will drive the demand for medicines.
Global Use of Medicines 2023 shows that the U.S. market spent about US$ 62.9 billion on medicines in 2022 on a net ex-factory basis. Overall growth slows as the Inflation Reduction Act (IRA) spends US$64 billion to reduce prescription drug prices, and the adoption of new treatments is expected to increase over the next few years. Besides, ex-factory discounts and rebates in drug distribution, the impact of patent expiration, and generic or biosimilar competition will also affect the U.S. pharmaceutical market.
This report presents a comprehensive overview, market shares, and growth opportunities of Biomarker of Disease market by product type, application, key players and key regions and countries.
Segmentation by Type:
Omics, proteomics, meta-bolomics technologies are used in biomarkers discovery and disease diagnosis. Biomarkers are used in risk assessment, molecular diagnostic, disease diagnosis, DNA fingerprinting and other molecular applications. Biomarkers enable pharmaceutical companies to analyze and discover novel drugs as demand for cost effective and efficient treatment dose is increasing. Biomarkers are used in drug validation and testing, sample preparation and assay development to eliminate complexity in discovery and development of novel drugs. Biomarkers of disease are used in identification of disease condition and also help in validation of clinical trials for novel drug.
The global Biomarker of Disease market size is projected to grow from US$ 31640 million in 2024 to US$ 79080 million in 2030; it is expected to grow at a CAGR of 16.5% from 2024 to 2030.
LPI (LP Information)' newest research report, the “Biomarker of Disease Industry Forecast” looks at past sales and reviews total world Biomarker of Disease sales in 2022, providing a comprehensive analysis by region and market sector of projected Biomarker of Disease sales for 2023 through 2029. With Biomarker of Disease sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Biomarker of Disease industry.
This Insight Report provides a comprehensive analysis of the global Biomarker of Disease landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Biomarker of Disease portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Biomarker of Disease market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Biomarker of Disease and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Biomarker of Disease.
According to the Global Use of Medicines 2023 released by IQVIA Institute, the global drug expenditure in 2022 was about US$1.48 trillion (excluding COVID vaccine and treatment-related expenses), and it is predicted to grow at a rate of 3%-6% in the next few years. In terms of drug expenditure, this number in China was about 166 billion dollars in 2022. It is expected that the expenditure on medicines will increase in the next few years. From the perspective of demand, the trend of population aging, the increase of residents’ wealth and the improvement of health awareness will drive the demand for medicines.
Global Use of Medicines 2023 shows that the U.S. market spent about US$ 62.9 billion on medicines in 2022 on a net ex-factory basis. Overall growth slows as the Inflation Reduction Act (IRA) spends US$64 billion to reduce prescription drug prices, and the adoption of new treatments is expected to increase over the next few years. Besides, ex-factory discounts and rebates in drug distribution, the impact of patent expiration, and generic or biosimilar competition will also affect the U.S. pharmaceutical market.
This report presents a comprehensive overview, market shares, and growth opportunities of Biomarker of Disease market by product type, application, key players and key regions and countries.
Segmentation by Type:
- Sample Preparation
- Assay Development
- Biomarker Validation and Testing
- Others
- Pharmaceutical Companies
- Government & Private Research Institutes
- Academic Institutes
- Medical Device Manufacturing Companies
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Sample Preparation
- Assay Development
- Biomarker Validation and Testing
- Others
- Pharmaceutical Companies
- Government & Private Research Institutes
- Academic Institutes
- Medical Device Manufacturing Companies
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Aushon Biosystem
- Bio-Rad Laboratories
- Thermo Fisher Scientific Inc
- Siemens AG
- Eisai Co. Ltd
- Roche Diagnostics Limited
- Abbott Laboratories, Inc
- Epistem Ltd
- Ge Healthcare
- Agilent Technologies Inc
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Biomarker of Disease Market Size 2019-2030
2.1.2 Biomarker of Disease Market Size CAGR by Region (2019 VS 2023 VS 2030)
2.1.3 World Current & Future Analysis for Biomarker of Disease by Country/Region, 2019, 2023 & 2030
2.2 Biomarker of Disease Segment by Type
2.2.1 Sample Preparation
2.2.2 Assay Development
2.2.3 Biomarker Validation and Testing
2.2.4 Others
2.3 Biomarker of Disease Market Size by Type
2.3.1 Biomarker of Disease Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Biomarker of Disease Market Size Market Share by Type (2019-2024)
2.4 Biomarker of Disease Segment by Application
2.4.1 Pharmaceutical Companies
2.4.2 Government & Private Research Institutes
2.4.3 Academic Institutes
2.4.4 Medical Device Manufacturing Companies
2.4.5 Others
2.5 Biomarker of Disease Market Size by Application
2.5.1 Biomarker of Disease Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Biomarker of Disease Market Size Market Share by Application (2019-2024)
3 BIOMARKER OF DISEASE MARKET SIZE BY PLAYER
3.1 Biomarker of Disease Market Size Market Share by Player
3.1.1 Global Biomarker of Disease Revenue by Player (2019-2024)
3.1.2 Global Biomarker of Disease Revenue Market Share by Player (2019-2024)
3.2 Global Biomarker of Disease Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 BIOMARKER OF DISEASE BY REGION
4.1 Biomarker of Disease Market Size by Region (2019-2024)
4.2 Global Biomarker of Disease Annual Revenue by Country/Region (2019-2024)
4.3 Americas Biomarker of Disease Market Size Growth (2019-2024)
4.4 APAC Biomarker of Disease Market Size Growth (2019-2024)
4.5 Europe Biomarker of Disease Market Size Growth (2019-2024)
4.6 Middle East & Africa Biomarker of Disease Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Biomarker of Disease Market Size by Country (2019-2024)
5.2 Americas Biomarker of Disease Market Size by Type (2019-2024)
5.3 Americas Biomarker of Disease Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Biomarker of Disease Market Size by Region (2019-2024)
6.2 APAC Biomarker of Disease Market Size by Type (2019-2024)
6.3 APAC Biomarker of Disease Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Biomarker of Disease Market Size by Country (2019-2024)
7.2 Europe Biomarker of Disease Market Size by Type (2019-2024)
7.3 Europe Biomarker of Disease Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Biomarker of Disease by Region (2019-2024)
8.2 Middle East & Africa Biomarker of Disease Market Size by Type (2019-2024)
8.3 Middle East & Africa Biomarker of Disease Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL BIOMARKER OF DISEASE MARKET FORECAST
10.1 Global Biomarker of Disease Forecast by Region (2025-2030)
10.1.1 Global Biomarker of Disease Forecast by Region (2025-2030)
10.1.2 Americas Biomarker of Disease Forecast
10.1.3 APAC Biomarker of Disease Forecast
10.1.4 Europe Biomarker of Disease Forecast
10.1.5 Middle East & Africa Biomarker of Disease Forecast
10.2 Americas Biomarker of Disease Forecast by Country (2025-2030)
10.2.1 United States Market Biomarker of Disease Forecast
10.2.2 Canada Market Biomarker of Disease Forecast
10.2.3 Mexico Market Biomarker of Disease Forecast
10.2.4 Brazil Market Biomarker of Disease Forecast
10.3 APAC Biomarker of Disease Forecast by Region (2025-2030)
10.3.1 China Biomarker of Disease Market Forecast
10.3.2 Japan Market Biomarker of Disease Forecast
10.3.3 Korea Market Biomarker of Disease Forecast
10.3.4 Southeast Asia Market Biomarker of Disease Forecast
10.3.5 India Market Biomarker of Disease Forecast
10.3.6 Australia Market Biomarker of Disease Forecast
10.4 Europe Biomarker of Disease Forecast by Country (2025-2030)
10.4.1 Germany Market Biomarker of Disease Forecast
10.4.2 France Market Biomarker of Disease Forecast
10.4.3 UK Market Biomarker of Disease Forecast
10.4.4 Italy Market Biomarker of Disease Forecast
10.4.5 Russia Market Biomarker of Disease Forecast
10.5 Middle East & Africa Biomarker of Disease Forecast by Region (2025-2030)
10.5.1 Egypt Market Biomarker of Disease Forecast
10.5.2 South Africa Market Biomarker of Disease Forecast
10.5.3 Israel Market Biomarker of Disease Forecast
10.5.4 Turkey Market Biomarker of Disease Forecast
10.6 Global Biomarker of Disease Forecast by Type (2025-2030)
10.7 Global Biomarker of Disease Forecast by Application (2025-2030)
10.7.1 GCC Countries Market Biomarker of Disease Forecast
11 KEY PLAYERS ANALYSIS
11.1 Aushon Biosystem
11.1.1 Aushon Biosystem Company Information
11.1.2 Aushon Biosystem Biomarker of Disease Product Offered
11.1.3 Aushon Biosystem Biomarker of Disease Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Aushon Biosystem Main Business Overview
11.1.5 Aushon Biosystem Latest Developments
11.2 Bio-Rad Laboratories
11.2.1 Bio-Rad Laboratories Company Information
11.2.2 Bio-Rad Laboratories Biomarker of Disease Product Offered
11.2.3 Bio-Rad Laboratories Biomarker of Disease Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Bio-Rad Laboratories Main Business Overview
11.2.5 Bio-Rad Laboratories Latest Developments
11.3 Thermo Fisher Scientific Inc
11.3.1 Thermo Fisher Scientific Inc Company Information
11.3.2 Thermo Fisher Scientific Inc Biomarker of Disease Product Offered
11.3.3 Thermo Fisher Scientific Inc Biomarker of Disease Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Thermo Fisher Scientific Inc Main Business Overview
11.3.5 Thermo Fisher Scientific Inc Latest Developments
11.4 Siemens AG
11.4.1 Siemens AG Company Information
11.4.2 Siemens AG Biomarker of Disease Product Offered
11.4.3 Siemens AG Biomarker of Disease Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Siemens AG Main Business Overview
11.4.5 Siemens AG Latest Developments
11.5 Eisai Co. Ltd
11.5.1 Eisai Co. Ltd Company Information
11.5.2 Eisai Co. Ltd Biomarker of Disease Product Offered
11.5.3 Eisai Co. Ltd Biomarker of Disease Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Eisai Co. Ltd Main Business Overview
11.5.5 Eisai Co. Ltd Latest Developments
11.6 Roche Diagnostics Limited
11.6.1 Roche Diagnostics Limited Company Information
11.6.2 Roche Diagnostics Limited Biomarker of Disease Product Offered
11.6.3 Roche Diagnostics Limited Biomarker of Disease Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Roche Diagnostics Limited Main Business Overview
11.6.5 Roche Diagnostics Limited Latest Developments
11.7 Abbott Laboratories, Inc
11.7.1 Abbott Laboratories, Inc Company Information
11.7.2 Abbott Laboratories, Inc Biomarker of Disease Product Offered
11.7.3 Abbott Laboratories, Inc Biomarker of Disease Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Abbott Laboratories, Inc Main Business Overview
11.7.5 Abbott Laboratories, Inc Latest Developments
11.8 Epistem Ltd
11.8.1 Epistem Ltd Company Information
11.8.2 Epistem Ltd Biomarker of Disease Product Offered
11.8.3 Epistem Ltd Biomarker of Disease Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Epistem Ltd Main Business Overview
11.8.5 Epistem Ltd Latest Developments
11.9 Ge Healthcare
11.9.1 Ge Healthcare Company Information
11.9.2 Ge Healthcare Biomarker of Disease Product Offered
11.9.3 Ge Healthcare Biomarker of Disease Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Ge Healthcare Main Business Overview
11.9.5 Ge Healthcare Latest Developments
11.10 Agilent Technologies Inc
11.10.1 Agilent Technologies Inc Company Information
11.10.2 Agilent Technologies Inc Biomarker of Disease Product Offered
11.10.3 Agilent Technologies Inc Biomarker of Disease Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Agilent Technologies Inc Main Business Overview
11.10.5 Agilent Technologies Inc Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Biomarker of Disease Market Size 2019-2030
2.1.2 Biomarker of Disease Market Size CAGR by Region (2019 VS 2023 VS 2030)
2.1.3 World Current & Future Analysis for Biomarker of Disease by Country/Region, 2019, 2023 & 2030
2.2 Biomarker of Disease Segment by Type
2.2.1 Sample Preparation
2.2.2 Assay Development
2.2.3 Biomarker Validation and Testing
2.2.4 Others
2.3 Biomarker of Disease Market Size by Type
2.3.1 Biomarker of Disease Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Biomarker of Disease Market Size Market Share by Type (2019-2024)
2.4 Biomarker of Disease Segment by Application
2.4.1 Pharmaceutical Companies
2.4.2 Government & Private Research Institutes
2.4.3 Academic Institutes
2.4.4 Medical Device Manufacturing Companies
2.4.5 Others
2.5 Biomarker of Disease Market Size by Application
2.5.1 Biomarker of Disease Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Biomarker of Disease Market Size Market Share by Application (2019-2024)
3 BIOMARKER OF DISEASE MARKET SIZE BY PLAYER
3.1 Biomarker of Disease Market Size Market Share by Player
3.1.1 Global Biomarker of Disease Revenue by Player (2019-2024)
3.1.2 Global Biomarker of Disease Revenue Market Share by Player (2019-2024)
3.2 Global Biomarker of Disease Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 BIOMARKER OF DISEASE BY REGION
4.1 Biomarker of Disease Market Size by Region (2019-2024)
4.2 Global Biomarker of Disease Annual Revenue by Country/Region (2019-2024)
4.3 Americas Biomarker of Disease Market Size Growth (2019-2024)
4.4 APAC Biomarker of Disease Market Size Growth (2019-2024)
4.5 Europe Biomarker of Disease Market Size Growth (2019-2024)
4.6 Middle East & Africa Biomarker of Disease Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Biomarker of Disease Market Size by Country (2019-2024)
5.2 Americas Biomarker of Disease Market Size by Type (2019-2024)
5.3 Americas Biomarker of Disease Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Biomarker of Disease Market Size by Region (2019-2024)
6.2 APAC Biomarker of Disease Market Size by Type (2019-2024)
6.3 APAC Biomarker of Disease Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Biomarker of Disease Market Size by Country (2019-2024)
7.2 Europe Biomarker of Disease Market Size by Type (2019-2024)
7.3 Europe Biomarker of Disease Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Biomarker of Disease by Region (2019-2024)
8.2 Middle East & Africa Biomarker of Disease Market Size by Type (2019-2024)
8.3 Middle East & Africa Biomarker of Disease Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL BIOMARKER OF DISEASE MARKET FORECAST
10.1 Global Biomarker of Disease Forecast by Region (2025-2030)
10.1.1 Global Biomarker of Disease Forecast by Region (2025-2030)
10.1.2 Americas Biomarker of Disease Forecast
10.1.3 APAC Biomarker of Disease Forecast
10.1.4 Europe Biomarker of Disease Forecast
10.1.5 Middle East & Africa Biomarker of Disease Forecast
10.2 Americas Biomarker of Disease Forecast by Country (2025-2030)
10.2.1 United States Market Biomarker of Disease Forecast
10.2.2 Canada Market Biomarker of Disease Forecast
10.2.3 Mexico Market Biomarker of Disease Forecast
10.2.4 Brazil Market Biomarker of Disease Forecast
10.3 APAC Biomarker of Disease Forecast by Region (2025-2030)
10.3.1 China Biomarker of Disease Market Forecast
10.3.2 Japan Market Biomarker of Disease Forecast
10.3.3 Korea Market Biomarker of Disease Forecast
10.3.4 Southeast Asia Market Biomarker of Disease Forecast
10.3.5 India Market Biomarker of Disease Forecast
10.3.6 Australia Market Biomarker of Disease Forecast
10.4 Europe Biomarker of Disease Forecast by Country (2025-2030)
10.4.1 Germany Market Biomarker of Disease Forecast
10.4.2 France Market Biomarker of Disease Forecast
10.4.3 UK Market Biomarker of Disease Forecast
10.4.4 Italy Market Biomarker of Disease Forecast
10.4.5 Russia Market Biomarker of Disease Forecast
10.5 Middle East & Africa Biomarker of Disease Forecast by Region (2025-2030)
10.5.1 Egypt Market Biomarker of Disease Forecast
10.5.2 South Africa Market Biomarker of Disease Forecast
10.5.3 Israel Market Biomarker of Disease Forecast
10.5.4 Turkey Market Biomarker of Disease Forecast
10.6 Global Biomarker of Disease Forecast by Type (2025-2030)
10.7 Global Biomarker of Disease Forecast by Application (2025-2030)
10.7.1 GCC Countries Market Biomarker of Disease Forecast
11 KEY PLAYERS ANALYSIS
11.1 Aushon Biosystem
11.1.1 Aushon Biosystem Company Information
11.1.2 Aushon Biosystem Biomarker of Disease Product Offered
11.1.3 Aushon Biosystem Biomarker of Disease Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Aushon Biosystem Main Business Overview
11.1.5 Aushon Biosystem Latest Developments
11.2 Bio-Rad Laboratories
11.2.1 Bio-Rad Laboratories Company Information
11.2.2 Bio-Rad Laboratories Biomarker of Disease Product Offered
11.2.3 Bio-Rad Laboratories Biomarker of Disease Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Bio-Rad Laboratories Main Business Overview
11.2.5 Bio-Rad Laboratories Latest Developments
11.3 Thermo Fisher Scientific Inc
11.3.1 Thermo Fisher Scientific Inc Company Information
11.3.2 Thermo Fisher Scientific Inc Biomarker of Disease Product Offered
11.3.3 Thermo Fisher Scientific Inc Biomarker of Disease Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Thermo Fisher Scientific Inc Main Business Overview
11.3.5 Thermo Fisher Scientific Inc Latest Developments
11.4 Siemens AG
11.4.1 Siemens AG Company Information
11.4.2 Siemens AG Biomarker of Disease Product Offered
11.4.3 Siemens AG Biomarker of Disease Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Siemens AG Main Business Overview
11.4.5 Siemens AG Latest Developments
11.5 Eisai Co. Ltd
11.5.1 Eisai Co. Ltd Company Information
11.5.2 Eisai Co. Ltd Biomarker of Disease Product Offered
11.5.3 Eisai Co. Ltd Biomarker of Disease Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Eisai Co. Ltd Main Business Overview
11.5.5 Eisai Co. Ltd Latest Developments
11.6 Roche Diagnostics Limited
11.6.1 Roche Diagnostics Limited Company Information
11.6.2 Roche Diagnostics Limited Biomarker of Disease Product Offered
11.6.3 Roche Diagnostics Limited Biomarker of Disease Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Roche Diagnostics Limited Main Business Overview
11.6.5 Roche Diagnostics Limited Latest Developments
11.7 Abbott Laboratories, Inc
11.7.1 Abbott Laboratories, Inc Company Information
11.7.2 Abbott Laboratories, Inc Biomarker of Disease Product Offered
11.7.3 Abbott Laboratories, Inc Biomarker of Disease Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Abbott Laboratories, Inc Main Business Overview
11.7.5 Abbott Laboratories, Inc Latest Developments
11.8 Epistem Ltd
11.8.1 Epistem Ltd Company Information
11.8.2 Epistem Ltd Biomarker of Disease Product Offered
11.8.3 Epistem Ltd Biomarker of Disease Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Epistem Ltd Main Business Overview
11.8.5 Epistem Ltd Latest Developments
11.9 Ge Healthcare
11.9.1 Ge Healthcare Company Information
11.9.2 Ge Healthcare Biomarker of Disease Product Offered
11.9.3 Ge Healthcare Biomarker of Disease Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Ge Healthcare Main Business Overview
11.9.5 Ge Healthcare Latest Developments
11.10 Agilent Technologies Inc
11.10.1 Agilent Technologies Inc Company Information
11.10.2 Agilent Technologies Inc Biomarker of Disease Product Offered
11.10.3 Agilent Technologies Inc Biomarker of Disease Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Agilent Technologies Inc Main Business Overview
11.10.5 Agilent Technologies Inc Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Biomarker of Disease Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ millions)
Table 2. Biomarker of Disease Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Sample Preparation
Table 4. Major Players of Assay Development
Table 5. Major Players of Biomarker Validation and Testing
Table 6. Major Players of Others
Table 7. Biomarker of Disease Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ millions)
Table 8. Global Biomarker of Disease Market Size by Type (2019-2024) & ($ millions)
Table 9. Global Biomarker of Disease Market Size Market Share by Type (2019-2024)
Table 10. Biomarker of Disease Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ millions)
Table 11. Global Biomarker of Disease Market Size by Application (2019-2024) & ($ millions)
Table 12. Global Biomarker of Disease Market Size Market Share by Application (2019-2024)
Table 13. Global Biomarker of Disease Revenue by Player (2019-2024) & ($ millions)
Table 14. Global Biomarker of Disease Revenue Market Share by Player (2019-2024)
Table 15. Biomarker of Disease Key Players Head office and Products Offered
Table 16. Biomarker of Disease Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 17. New Products and Potential Entrants
Table 18. Mergers & Acquisitions, Expansion
Table 19. Global Biomarker of Disease Market Size by Region (2019-2024) & ($ millions)
Table 20. Global Biomarker of Disease Market Size Market Share by Region (2019-2024)
Table 21. Global Biomarker of Disease Revenue by Country/Region (2019-2024) & ($ millions)
Table 22. Global Biomarker of Disease Revenue Market Share by Country/Region (2019-2024)
Table 23. Americas Biomarker of Disease Market Size by Country (2019-2024) & ($ millions)
Table 24. Americas Biomarker of Disease Market Size Market Share by Country (2019-2024)
Table 25. Americas Biomarker of Disease Market Size by Type (2019-2024) & ($ millions)
Table 26. Americas Biomarker of Disease Market Size Market Share by Type (2019-2024)
Table 27. Americas Biomarker of Disease Market Size by Application (2019-2024) & ($ millions)
Table 28. Americas Biomarker of Disease Market Size Market Share by Application (2019-2024)
Table 29. APAC Biomarker of Disease Market Size by Region (2019-2024) & ($ millions)
Table 30. APAC Biomarker of Disease Market Size Market Share by Region (2019-2024)
Table 31. APAC Biomarker of Disease Market Size by Type (2019-2024) & ($ millions)
Table 32. APAC Biomarker of Disease Market Size by Application (2019-2024) & ($ millions)
Table 33. Europe Biomarker of Disease Market Size by Country (2019-2024) & ($ millions)
Table 34. Europe Biomarker of Disease Market Size Market Share by Country (2019-2024)
Table 35. Europe Biomarker of Disease Market Size by Type (2019-2024) & ($ millions)
Table 36. Europe Biomarker of Disease Market Size by Application (2019-2024) & ($ millions)
Table 37. Middle East & Africa Biomarker of Disease Market Size by Region (2019-2024) & ($ millions)
Table 38. Middle East & Africa Biomarker of Disease Market Size by Type (2019-2024) & ($ millions)
Table 39. Middle East & Africa Biomarker of Disease Market Size by Application (2019-2024) & ($ millions)
Table 40. Key Market Drivers & Growth Opportunities of Biomarker of Disease
Table 41. Key Market Challenges & Risks of Biomarker of Disease
Table 42. Key Industry Trends of Biomarker of Disease
Table 43. Global Biomarker of Disease Market Size Forecast by Region (2025-2030) & ($ millions)
Table 44. Global Biomarker of Disease Market Size Market Share Forecast by Region (2025-2030)
Table 45. Global Biomarker of Disease Market Size Forecast by Type (2025-2030) & ($ millions)
Table 46. Global Biomarker of Disease Market Size Forecast by Application (2025-2030) & ($ millions)
Table 47. Aushon Biosystem Details, Company Type, Biomarker of Disease Area Served and Its Competitors
Table 48. Aushon Biosystem Biomarker of Disease Product Offered
Table 49. Aushon Biosystem Biomarker of Disease Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 50. Aushon Biosystem Main Business
Table 51. Aushon Biosystem Latest Developments
Table 52. Bio-Rad Laboratories Details, Company Type, Biomarker of Disease Area Served and Its Competitors
Table 53. Bio-Rad Laboratories Biomarker of Disease Product Offered
Table 54. Bio-Rad Laboratories Biomarker of Disease Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 55. Bio-Rad Laboratories Main Business
Table 56. Bio-Rad Laboratories Latest Developments
Table 57. Thermo Fisher Scientific Inc Details, Company Type, Biomarker of Disease Area Served and Its Competitors
Table 58. Thermo Fisher Scientific Inc Biomarker of Disease Product Offered
Table 59. Thermo Fisher Scientific Inc Biomarker of Disease Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 60. Thermo Fisher Scientific Inc Main Business
Table 61. Thermo Fisher Scientific Inc Latest Developments
Table 62. Siemens AG Details, Company Type, Biomarker of Disease Area Served and Its Competitors
Table 63. Siemens AG Biomarker of Disease Product Offered
Table 64. Siemens AG Biomarker of Disease Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 65. Siemens AG Main Business
Table 66. Siemens AG Latest Developments
Table 67. Eisai Co. Ltd Details, Company Type, Biomarker of Disease Area Served and Its Competitors
Table 68. Eisai Co. Ltd Biomarker of Disease Product Offered
Table 69. Eisai Co. Ltd Biomarker of Disease Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 70. Eisai Co. Ltd Main Business
Table 71. Eisai Co. Ltd Latest Developments
Table 72. Roche Diagnostics Limited Details, Company Type, Biomarker of Disease Area Served and Its Competitors
Table 73. Roche Diagnostics Limited Biomarker of Disease Product Offered
Table 74. Roche Diagnostics Limited Biomarker of Disease Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 75. Roche Diagnostics Limited Main Business
Table 76. Roche Diagnostics Limited Latest Developments
Table 77. Abbott Laboratories, Inc Details, Company Type, Biomarker of Disease Area Served and Its Competitors
Table 78. Abbott Laboratories, Inc Biomarker of Disease Product Offered
Table 79. Abbott Laboratories, Inc Biomarker of Disease Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 80. Abbott Laboratories, Inc Main Business
Table 81. Abbott Laboratories, Inc Latest Developments
Table 82. Epistem Ltd Details, Company Type, Biomarker of Disease Area Served and Its Competitors
Table 83. Epistem Ltd Biomarker of Disease Product Offered
Table 84. Epistem Ltd Biomarker of Disease Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 85. Epistem Ltd Main Business
Table 86. Epistem Ltd Latest Developments
Table 87. Ge Healthcare Details, Company Type, Biomarker of Disease Area Served and Its Competitors
Table 88. Ge Healthcare Biomarker of Disease Product Offered
Table 89. Ge Healthcare Biomarker of Disease Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 90. Ge Healthcare Main Business
Table 91. Ge Healthcare Latest Developments
Table 92. Agilent Technologies Inc Details, Company Type, Biomarker of Disease Area Served and Its Competitors
Table 93. Agilent Technologies Inc Biomarker of Disease Product Offered
Table 94. Agilent Technologies Inc Biomarker of Disease Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 95. Agilent Technologies Inc Main Business
Table 96. Agilent Technologies Inc Latest Developments
Table 1. Biomarker of Disease Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ millions)
Table 2. Biomarker of Disease Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Sample Preparation
Table 4. Major Players of Assay Development
Table 5. Major Players of Biomarker Validation and Testing
Table 6. Major Players of Others
Table 7. Biomarker of Disease Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ millions)
Table 8. Global Biomarker of Disease Market Size by Type (2019-2024) & ($ millions)
Table 9. Global Biomarker of Disease Market Size Market Share by Type (2019-2024)
Table 10. Biomarker of Disease Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ millions)
Table 11. Global Biomarker of Disease Market Size by Application (2019-2024) & ($ millions)
Table 12. Global Biomarker of Disease Market Size Market Share by Application (2019-2024)
Table 13. Global Biomarker of Disease Revenue by Player (2019-2024) & ($ millions)
Table 14. Global Biomarker of Disease Revenue Market Share by Player (2019-2024)
Table 15. Biomarker of Disease Key Players Head office and Products Offered
Table 16. Biomarker of Disease Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 17. New Products and Potential Entrants
Table 18. Mergers & Acquisitions, Expansion
Table 19. Global Biomarker of Disease Market Size by Region (2019-2024) & ($ millions)
Table 20. Global Biomarker of Disease Market Size Market Share by Region (2019-2024)
Table 21. Global Biomarker of Disease Revenue by Country/Region (2019-2024) & ($ millions)
Table 22. Global Biomarker of Disease Revenue Market Share by Country/Region (2019-2024)
Table 23. Americas Biomarker of Disease Market Size by Country (2019-2024) & ($ millions)
Table 24. Americas Biomarker of Disease Market Size Market Share by Country (2019-2024)
Table 25. Americas Biomarker of Disease Market Size by Type (2019-2024) & ($ millions)
Table 26. Americas Biomarker of Disease Market Size Market Share by Type (2019-2024)
Table 27. Americas Biomarker of Disease Market Size by Application (2019-2024) & ($ millions)
Table 28. Americas Biomarker of Disease Market Size Market Share by Application (2019-2024)
Table 29. APAC Biomarker of Disease Market Size by Region (2019-2024) & ($ millions)
Table 30. APAC Biomarker of Disease Market Size Market Share by Region (2019-2024)
Table 31. APAC Biomarker of Disease Market Size by Type (2019-2024) & ($ millions)
Table 32. APAC Biomarker of Disease Market Size by Application (2019-2024) & ($ millions)
Table 33. Europe Biomarker of Disease Market Size by Country (2019-2024) & ($ millions)
Table 34. Europe Biomarker of Disease Market Size Market Share by Country (2019-2024)
Table 35. Europe Biomarker of Disease Market Size by Type (2019-2024) & ($ millions)
Table 36. Europe Biomarker of Disease Market Size by Application (2019-2024) & ($ millions)
Table 37. Middle East & Africa Biomarker of Disease Market Size by Region (2019-2024) & ($ millions)
Table 38. Middle East & Africa Biomarker of Disease Market Size by Type (2019-2024) & ($ millions)
Table 39. Middle East & Africa Biomarker of Disease Market Size by Application (2019-2024) & ($ millions)
Table 40. Key Market Drivers & Growth Opportunities of Biomarker of Disease
Table 41. Key Market Challenges & Risks of Biomarker of Disease
Table 42. Key Industry Trends of Biomarker of Disease
Table 43. Global Biomarker of Disease Market Size Forecast by Region (2025-2030) & ($ millions)
Table 44. Global Biomarker of Disease Market Size Market Share Forecast by Region (2025-2030)
Table 45. Global Biomarker of Disease Market Size Forecast by Type (2025-2030) & ($ millions)
Table 46. Global Biomarker of Disease Market Size Forecast by Application (2025-2030) & ($ millions)
Table 47. Aushon Biosystem Details, Company Type, Biomarker of Disease Area Served and Its Competitors
Table 48. Aushon Biosystem Biomarker of Disease Product Offered
Table 49. Aushon Biosystem Biomarker of Disease Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 50. Aushon Biosystem Main Business
Table 51. Aushon Biosystem Latest Developments
Table 52. Bio-Rad Laboratories Details, Company Type, Biomarker of Disease Area Served and Its Competitors
Table 53. Bio-Rad Laboratories Biomarker of Disease Product Offered
Table 54. Bio-Rad Laboratories Biomarker of Disease Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 55. Bio-Rad Laboratories Main Business
Table 56. Bio-Rad Laboratories Latest Developments
Table 57. Thermo Fisher Scientific Inc Details, Company Type, Biomarker of Disease Area Served and Its Competitors
Table 58. Thermo Fisher Scientific Inc Biomarker of Disease Product Offered
Table 59. Thermo Fisher Scientific Inc Biomarker of Disease Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 60. Thermo Fisher Scientific Inc Main Business
Table 61. Thermo Fisher Scientific Inc Latest Developments
Table 62. Siemens AG Details, Company Type, Biomarker of Disease Area Served and Its Competitors
Table 63. Siemens AG Biomarker of Disease Product Offered
Table 64. Siemens AG Biomarker of Disease Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 65. Siemens AG Main Business
Table 66. Siemens AG Latest Developments
Table 67. Eisai Co. Ltd Details, Company Type, Biomarker of Disease Area Served and Its Competitors
Table 68. Eisai Co. Ltd Biomarker of Disease Product Offered
Table 69. Eisai Co. Ltd Biomarker of Disease Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 70. Eisai Co. Ltd Main Business
Table 71. Eisai Co. Ltd Latest Developments
Table 72. Roche Diagnostics Limited Details, Company Type, Biomarker of Disease Area Served and Its Competitors
Table 73. Roche Diagnostics Limited Biomarker of Disease Product Offered
Table 74. Roche Diagnostics Limited Biomarker of Disease Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 75. Roche Diagnostics Limited Main Business
Table 76. Roche Diagnostics Limited Latest Developments
Table 77. Abbott Laboratories, Inc Details, Company Type, Biomarker of Disease Area Served and Its Competitors
Table 78. Abbott Laboratories, Inc Biomarker of Disease Product Offered
Table 79. Abbott Laboratories, Inc Biomarker of Disease Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 80. Abbott Laboratories, Inc Main Business
Table 81. Abbott Laboratories, Inc Latest Developments
Table 82. Epistem Ltd Details, Company Type, Biomarker of Disease Area Served and Its Competitors
Table 83. Epistem Ltd Biomarker of Disease Product Offered
Table 84. Epistem Ltd Biomarker of Disease Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 85. Epistem Ltd Main Business
Table 86. Epistem Ltd Latest Developments
Table 87. Ge Healthcare Details, Company Type, Biomarker of Disease Area Served and Its Competitors
Table 88. Ge Healthcare Biomarker of Disease Product Offered
Table 89. Ge Healthcare Biomarker of Disease Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 90. Ge Healthcare Main Business
Table 91. Ge Healthcare Latest Developments
Table 92. Agilent Technologies Inc Details, Company Type, Biomarker of Disease Area Served and Its Competitors
Table 93. Agilent Technologies Inc Biomarker of Disease Product Offered
Table 94. Agilent Technologies Inc Biomarker of Disease Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 95. Agilent Technologies Inc Main Business
Table 96. Agilent Technologies Inc Latest Developments
LIST OF FIGURES
Figure 1. Biomarker of Disease Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Biomarker of Disease Market Size Growth Rate 2019-2030 ($ millions)
Figure 6. Biomarker of Disease Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Biomarker of Disease Sales Market Share by Country/Region (2023)
Figure 8. Biomarker of Disease Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Biomarker of Disease Market Size Market Share by Type in 2023
Figure 10. Biomarker of Disease in Pharmaceutical Companies
Figure 11. Global Biomarker of Disease Market: Pharmaceutical Companies (2019-2024) & ($ millions)
Figure 12. Biomarker of Disease in Government & Private Research Institutes
Figure 13. Global Biomarker of Disease Market: Government & Private Research Institutes (2019-2024) & ($ millions)
Figure 14. Biomarker of Disease in Academic Institutes
Figure 15. Global Biomarker of Disease Market: Academic Institutes (2019-2024) & ($ millions)
Figure 16. Biomarker of Disease in Medical Device Manufacturing Companies
Figure 17. Global Biomarker of Disease Market: Medical Device Manufacturing Companies (2019-2024) & ($ millions)
Figure 18. Biomarker of Disease in Others
Figure 19. Global Biomarker of Disease Market: Others (2019-2024) & ($ millions)
Figure 20. Global Biomarker of Disease Market Size Market Share by Application in 2023
Figure 21. Global Biomarker of Disease Revenue Market Share by Player in 2023
Figure 22. Global Biomarker of Disease Market Size Market Share by Region (2019-2024)
Figure 23. Americas Biomarker of Disease Market Size 2019-2024 ($ millions)
Figure 24. APAC Biomarker of Disease Market Size 2019-2024 ($ millions)
Figure 25. Europe Biomarker of Disease Market Size 2019-2024 ($ millions)
Figure 26. Middle East & Africa Biomarker of Disease Market Size 2019-2024 ($ millions)
Figure 27. Americas Biomarker of Disease Value Market Share by Country in 2023
Figure 28. United States Biomarker of Disease Market Size Growth 2019-2024 ($ millions)
Figure 29. Canada Biomarker of Disease Market Size Growth 2019-2024 ($ millions)
Figure 30. Mexico Biomarker of Disease Market Size Growth 2019-2024 ($ millions)
Figure 31. Brazil Biomarker of Disease Market Size Growth 2019-2024 ($ millions)
Figure 32. APAC Biomarker of Disease Market Size Market Share by Region in 2023
Figure 33. APAC Biomarker of Disease Market Size Market Share by Type (2019-2024)
Figure 34. APAC Biomarker of Disease Market Size Market Share by Application (2019-2024)
Figure 35. China Biomarker of Disease Market Size Growth 2019-2024 ($ millions)
Figure 36. Japan Biomarker of Disease Market Size Growth 2019-2024 ($ millions)
Figure 37. South Korea Biomarker of Disease Market Size Growth 2019-2024 ($ millions)
Figure 38. Southeast Asia Biomarker of Disease Market Size Growth 2019-2024 ($ millions)
Figure 39. India Biomarker of Disease Market Size Growth 2019-2024 ($ millions)
Figure 40. Australia Biomarker of Disease Market Size Growth 2019-2024 ($ millions)
Figure 41. Europe Biomarker of Disease Market Size Market Share by Country in 2023
Figure 42. Europe Biomarker of Disease Market Size Market Share by Type (2019-2024)
Figure 43. Europe Biomarker of Disease Market Size Market Share by Application (2019-2024)
Figure 44. Germany Biomarker of Disease Market Size Growth 2019-2024 ($ millions)
Figure 45. France Biomarker of Disease Market Size Growth 2019-2024 ($ millions)
Figure 46. UK Biomarker of Disease Market Size Growth 2019-2024 ($ millions)
Figure 47. Italy Biomarker of Disease Market Size Growth 2019-2024 ($ millions)
Figure 48. Russia Biomarker of Disease Market Size Growth 2019-2024 ($ millions)
Figure 49. Middle East & Africa Biomarker of Disease Market Size Market Share by Region (2019-2024)
Figure 50. Middle East & Africa Biomarker of Disease Market Size Market Share by Type (2019-2024)
Figure 51. Middle East & Africa Biomarker of Disease Market Size Market Share by Application (2019-2024)
Figure 52. Egypt Biomarker of Disease Market Size Growth 2019-2024 ($ millions)
Figure 53. South Africa Biomarker of Disease Market Size Growth 2019-2024 ($ millions)
Figure 54. Israel Biomarker of Disease Market Size Growth 2019-2024 ($ millions)
Figure 55. Turkey Biomarker of Disease Market Size Growth 2019-2024 ($ millions)
Figure 56. GCC Countries Biomarker of Disease Market Size Growth 2019-2024 ($ millions)
Figure 57. Americas Biomarker of Disease Market Size 2025-2030 ($ millions)
Figure 58. APAC Biomarker of Disease Market Size 2025-2030 ($ millions)
Figure 59. Europe Biomarker of Disease Market Size 2025-2030 ($ millions)
Figure 60. Middle East & Africa Biomarker of Disease Market Size 2025-2030 ($ millions)
Figure 61. United States Biomarker of Disease Market Size 2025-2030 ($ millions)
Figure 62. Canada Biomarker of Disease Market Size 2025-2030 ($ millions)
Figure 63. Mexico Biomarker of Disease Market Size 2025-2030 ($ millions)
Figure 64. Brazil Biomarker of Disease Market Size 2025-2030 ($ millions)
Figure 65. China Biomarker of Disease Market Size 2025-2030 ($ millions)
Figure 66. Japan Biomarker of Disease Market Size 2025-2030 ($ millions)
Figure 67. Korea Biomarker of Disease Market Size 2025-2030 ($ millions)
Figure 68. Southeast Asia Biomarker of Disease Market Size 2025-2030 ($ millions)
Figure 69. India Biomarker of Disease Market Size 2025-2030 ($ millions)
Figure 70. Australia Biomarker of Disease Market Size 2025-2030 ($ millions)
Figure 71. Germany Biomarker of Disease Market Size 2025-2030 ($ millions)
Figure 72. France Biomarker of Disease Market Size 2025-2030 ($ millions)
Figure 73. UK Biomarker of Disease Market Size 2025-2030 ($ millions)
Figure 74. Italy Biomarker of Disease Market Size 2025-2030 ($ millions)
Figure 75. Russia Biomarker of Disease Market Size 2025-2030 ($ millions)
Figure 76. Egypt Biomarker of Disease Market Size 2025-2030 ($ millions)
Figure 77. South Africa Biomarker of Disease Market Size 2025-2030 ($ millions)
Figure 78. Israel Biomarker of Disease Market Size 2025-2030 ($ millions)
Figure 79. Turkey Biomarker of Disease Market Size 2025-2030 ($ millions)
Figure 80. GCC Countries Biomarker of Disease Market Size 2025-2030 ($ millions)
Figure 81. Global Biomarker of Disease Market Size Market Share Forecast by Type (2025-2030)
Figure 82. Global Biomarker of Disease Market Size Market Share Forecast by Application (2025-2030)
Figure 1. Biomarker of Disease Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Biomarker of Disease Market Size Growth Rate 2019-2030 ($ millions)
Figure 6. Biomarker of Disease Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Biomarker of Disease Sales Market Share by Country/Region (2023)
Figure 8. Biomarker of Disease Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Biomarker of Disease Market Size Market Share by Type in 2023
Figure 10. Biomarker of Disease in Pharmaceutical Companies
Figure 11. Global Biomarker of Disease Market: Pharmaceutical Companies (2019-2024) & ($ millions)
Figure 12. Biomarker of Disease in Government & Private Research Institutes
Figure 13. Global Biomarker of Disease Market: Government & Private Research Institutes (2019-2024) & ($ millions)
Figure 14. Biomarker of Disease in Academic Institutes
Figure 15. Global Biomarker of Disease Market: Academic Institutes (2019-2024) & ($ millions)
Figure 16. Biomarker of Disease in Medical Device Manufacturing Companies
Figure 17. Global Biomarker of Disease Market: Medical Device Manufacturing Companies (2019-2024) & ($ millions)
Figure 18. Biomarker of Disease in Others
Figure 19. Global Biomarker of Disease Market: Others (2019-2024) & ($ millions)
Figure 20. Global Biomarker of Disease Market Size Market Share by Application in 2023
Figure 21. Global Biomarker of Disease Revenue Market Share by Player in 2023
Figure 22. Global Biomarker of Disease Market Size Market Share by Region (2019-2024)
Figure 23. Americas Biomarker of Disease Market Size 2019-2024 ($ millions)
Figure 24. APAC Biomarker of Disease Market Size 2019-2024 ($ millions)
Figure 25. Europe Biomarker of Disease Market Size 2019-2024 ($ millions)
Figure 26. Middle East & Africa Biomarker of Disease Market Size 2019-2024 ($ millions)
Figure 27. Americas Biomarker of Disease Value Market Share by Country in 2023
Figure 28. United States Biomarker of Disease Market Size Growth 2019-2024 ($ millions)
Figure 29. Canada Biomarker of Disease Market Size Growth 2019-2024 ($ millions)
Figure 30. Mexico Biomarker of Disease Market Size Growth 2019-2024 ($ millions)
Figure 31. Brazil Biomarker of Disease Market Size Growth 2019-2024 ($ millions)
Figure 32. APAC Biomarker of Disease Market Size Market Share by Region in 2023
Figure 33. APAC Biomarker of Disease Market Size Market Share by Type (2019-2024)
Figure 34. APAC Biomarker of Disease Market Size Market Share by Application (2019-2024)
Figure 35. China Biomarker of Disease Market Size Growth 2019-2024 ($ millions)
Figure 36. Japan Biomarker of Disease Market Size Growth 2019-2024 ($ millions)
Figure 37. South Korea Biomarker of Disease Market Size Growth 2019-2024 ($ millions)
Figure 38. Southeast Asia Biomarker of Disease Market Size Growth 2019-2024 ($ millions)
Figure 39. India Biomarker of Disease Market Size Growth 2019-2024 ($ millions)
Figure 40. Australia Biomarker of Disease Market Size Growth 2019-2024 ($ millions)
Figure 41. Europe Biomarker of Disease Market Size Market Share by Country in 2023
Figure 42. Europe Biomarker of Disease Market Size Market Share by Type (2019-2024)
Figure 43. Europe Biomarker of Disease Market Size Market Share by Application (2019-2024)
Figure 44. Germany Biomarker of Disease Market Size Growth 2019-2024 ($ millions)
Figure 45. France Biomarker of Disease Market Size Growth 2019-2024 ($ millions)
Figure 46. UK Biomarker of Disease Market Size Growth 2019-2024 ($ millions)
Figure 47. Italy Biomarker of Disease Market Size Growth 2019-2024 ($ millions)
Figure 48. Russia Biomarker of Disease Market Size Growth 2019-2024 ($ millions)
Figure 49. Middle East & Africa Biomarker of Disease Market Size Market Share by Region (2019-2024)
Figure 50. Middle East & Africa Biomarker of Disease Market Size Market Share by Type (2019-2024)
Figure 51. Middle East & Africa Biomarker of Disease Market Size Market Share by Application (2019-2024)
Figure 52. Egypt Biomarker of Disease Market Size Growth 2019-2024 ($ millions)
Figure 53. South Africa Biomarker of Disease Market Size Growth 2019-2024 ($ millions)
Figure 54. Israel Biomarker of Disease Market Size Growth 2019-2024 ($ millions)
Figure 55. Turkey Biomarker of Disease Market Size Growth 2019-2024 ($ millions)
Figure 56. GCC Countries Biomarker of Disease Market Size Growth 2019-2024 ($ millions)
Figure 57. Americas Biomarker of Disease Market Size 2025-2030 ($ millions)
Figure 58. APAC Biomarker of Disease Market Size 2025-2030 ($ millions)
Figure 59. Europe Biomarker of Disease Market Size 2025-2030 ($ millions)
Figure 60. Middle East & Africa Biomarker of Disease Market Size 2025-2030 ($ millions)
Figure 61. United States Biomarker of Disease Market Size 2025-2030 ($ millions)
Figure 62. Canada Biomarker of Disease Market Size 2025-2030 ($ millions)
Figure 63. Mexico Biomarker of Disease Market Size 2025-2030 ($ millions)
Figure 64. Brazil Biomarker of Disease Market Size 2025-2030 ($ millions)
Figure 65. China Biomarker of Disease Market Size 2025-2030 ($ millions)
Figure 66. Japan Biomarker of Disease Market Size 2025-2030 ($ millions)
Figure 67. Korea Biomarker of Disease Market Size 2025-2030 ($ millions)
Figure 68. Southeast Asia Biomarker of Disease Market Size 2025-2030 ($ millions)
Figure 69. India Biomarker of Disease Market Size 2025-2030 ($ millions)
Figure 70. Australia Biomarker of Disease Market Size 2025-2030 ($ millions)
Figure 71. Germany Biomarker of Disease Market Size 2025-2030 ($ millions)
Figure 72. France Biomarker of Disease Market Size 2025-2030 ($ millions)
Figure 73. UK Biomarker of Disease Market Size 2025-2030 ($ millions)
Figure 74. Italy Biomarker of Disease Market Size 2025-2030 ($ millions)
Figure 75. Russia Biomarker of Disease Market Size 2025-2030 ($ millions)
Figure 76. Egypt Biomarker of Disease Market Size 2025-2030 ($ millions)
Figure 77. South Africa Biomarker of Disease Market Size 2025-2030 ($ millions)
Figure 78. Israel Biomarker of Disease Market Size 2025-2030 ($ millions)
Figure 79. Turkey Biomarker of Disease Market Size 2025-2030 ($ millions)
Figure 80. GCC Countries Biomarker of Disease Market Size 2025-2030 ($ millions)
Figure 81. Global Biomarker of Disease Market Size Market Share Forecast by Type (2025-2030)
Figure 82. Global Biomarker of Disease Market Size Market Share Forecast by Application (2025-2030)
